Patent Law Updates | New Statutes, Regulations and Rules

August 15, 2012

USPTO Publishes Final Rules for the Citation of Prior Art and Written Statements Provision of the America Invents Act

Changes to Implement Miscellaneous Post Patent Provisions of the Leahy-Smith America Invents Act
USPTO No. 12-48, 37 CFR Parts 1, 5, 10, 11, and 41, Docket No. PTO-P-2011-0072, RIN 0651-AC66, 8/6/2012

USPTO Publishes Final Rules for the Citation of Prior Art and Written Statements Provision of the America Invents Act

The U.S. Department of Commerce’s United States Patent and Trademark Office (USPTO) has published final rules in the Federal Register to implement the Citation of Prior Art and Written Statements provision of the Leahy-Smith America Invents Act (AIA).

This AIA provision expands the type of information that a patent owner or third party may submit into a patent file. It will allow submission of patent owner statements about claim scope that were made in a federal court or a USPTO proceeding.

The provision also defines how the Office may use such information during ex parte reexamination, inter partes reexamination, and post grant review. The citation of prior art and written statements provision of the AIA becomes effective on September 16, 2012. Release of this final rule follows a public comment period on the proposed rule earlier this year.

“The citation of prior art and written statements provision of the America Invents Act ensures that any statements a patent owner makes about the scope of the patent claim will be known to the courts as well as to the Office,” said Under Secretary of Commerce for Intellectual Property and Director of the USPTO David Kappos. “We’re pleased to have them posted in the Federal Register well before the effective date.”

The USPTO plans to discuss the final rules for citing prior art and written statements at “roadshows” scheduled for September 2012 in Alexandria, Va., Atlanta, Denver, Detroit, Houston, Los Angeles, Minneapolis, and New York.

View a PDF of the rule

Also See:

Strong Growth in Demand for Intellectual Property Rights in 2012 – WIPO

USPTO Updates Professional Conduct Rules and Registration Examination for Patent Attorneys

Expanded SHIELD Act Filed to Combat Patent Trolls

USPTO Publishes Final Rules and Guidelines Governing First-Inventor-to-File

USPTO Seeking Comments on Matters Related to the Harmonization of Substantive Patent Law

The most advanced document                
         management system in the world.

Only $59 / person / month
FeaturesLawLoop Demo
FeaturesWelcome to the Future
Play LawLoop Demo

Companies Mentioned

Patent Law

The following companies are mentioned in Patent Law Updates:

Boston Scientific Corp.

Microsoft Corp.

Cordis Corp.

Boston Scientific Scimed, Inc.

Samsung Electronics America, Inc.

U.S. Patent and Trademark Office

Stryker Corp.

Quanta Computer, Inc.

LG Electronics, Inc.

Scimed Life Systems Inc.

Cohesive Technologies, Inc.

Waters Corp.

Swisa, Inc.

Egyptian Goddess, Inc.

Nokia, Inc.

Dror Swisa

Johnson & Johnson, Inc.

Target Corp.

Sears Holding Corp.

Smith & Nephew, Inc.

Sanyo North America Corp.

Prometheus Laboratories, Inc.

Kohl’s Department Stores, Inc.

Mayo Collaborative Services d.b.a. Mayo Medical Laboratories

K-Mart Corp.

McKesson Information Solutions, Inc.

J.C. Penney Company, Inc.

Bridge Medical, Inc.

Motorola, Inc.

Glamourmom LLC

Honeywell International, Inc.

Federated Department Stores

Elizabeth Lange LLC d.b.a. Liz Lange Maternity

United States Patent and Trademark Office

SmithKline Beecham PLC

Smithkline Beecham Corp. (d.b.a. GlaxoSmithKline, plc.)

SmithKline Beecham Corp. d.b.a GlaxoSmithKline

HT Window Fashion Corp.

Glaxo Group Limited d.b.a. GlaxoSmithKline

Ortho-McNeil Pharmaceutical, Inc.

Ranbaxy, Inc.

Mylan Pharmaceutical, Inc.

Teva Pharmaceuticals USA, Inc.

Mylan Laboratories, Inc.

Stryker Sales Corp.

Stryker Orthopaedics

Audiovox Communications Corp.

Howmedica Osteonics Corp.

Acumed, LLC

Ranbaxy Laboratories, Ltd.

Additional Resources

Patent Law

Further Reading in Patent Law

Other Recent Summaries

Recent Expert Legal Commentaries